LIVE NOW: FDA Holds Public Meeting on Rare Disease Drug Development Framework

The U.S. Food and Drug Administration, in partnership with the Reagan-Udall Foundation for the FDA, holds a hybrid public meeting at 1 p.m. ET on Oct. 28 to gather input on its Rare Disease Framework Initiative. The meeting focuses on improving regulatory approaches to rare disease drug development, including evidence requirements, regulatory consistency, patient engagement, […]